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Sicklick and Rubinstein: A Medical Review of AIDS

A MEDICAL REVIEW OF AIDS
Marc J. Sicklick, M.D.* and Arye Rubinstein, M.D.**
CASE DEFINITION
AIDS1 is defined by the Centers for Disease Control (CDC) as
an acquired immune deficiency syndrome in association with evidence of exposure to the Human T-cell lymphotropic retrovirus type
III (HTLV-III) in a person who is not otherwise at risk for developing an immune deficiency syndrome. This definition excludes any
immune deficiencies accompanying malignancies or immune deficiencies which are induced by immunosuppressive medications (such
as those given to organ transplant recipients). 3
Certain disease symptoms must be documented in order to support a diagnosis of AIDS." These symptoms include: opportunistic
infection (infection with an organism that does not usually cause disease); Kaposi's sarcoma (a malignant skin lesion that is normally
not found in young individuals); non-Hodgkin's lymphoma of high
grade pathogenicity; or, in children under age thirteen, a lymphocytic (white blood cell) infiltrative process in the lung.'
The CDC case definition was established primarily for an epidemiologic survey. However, physicians recognize many patients as
being HTLV-III infected who do not fit the CDC criteria for AIDS,
and who, therefore, are not included in published statistical and de* Marc J. Sicklick, M.D., is an Associate Clinical Professor of Pediatrics; Co-Director,
Division of Allergy-Immunology at the Albert Einstein College of Medicine.
** Arye Rubinstein, M.D., is a Professor of Pediatrics, Microbiology and Immunology;
Director, Division of Allergy-Immunology at the Albert Einstein College of Medicine.
1. AIDS is the abbreviation for acquired immune deficiency syndrome.
2. Selik, Haverkos & Curran, Acquired Immune Deficiency Syndrome (AIDS) Trends
in the United States, 1978-1982, 76 AM. J. MED. 493 (1984).
3. Jaffe, Bregman & Selik, Acquired Immune Deficiency Syndrome in the United
States: The First 1,000 Cases, 148 J. INFECTIOUs DISEASES 339 (1983).
4. Selik, Haverkos & Curran, supra note 2, at 499.

5. Id.
6.

Revision of the Case Definition of Acquired Immunodeficiency Syndrome for NaMORBIDITY & MORTALITY WEEKLY REP. 373 (June 28,

tional Reporting-UnitedStates, 34
1985).
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mographic CDC reports.7 As a result, the original case definition of
AIDS is modified as the disease is better understood and as new
clinical patterns evolve. 8
For the nonepidemiologist, it is helpful to think of AIDS as a
spectrum of HTLV-III diseases ranging from HTLV-III infection in
a healthy person, to recurrent nonopportunistic infections, to full
blown AIDS as it is currently defined." Any disease associated with
HTLV-III infection that does not fall far enough into the spectrum
to be classified as AIDS is called AIDS-related complex (ARC).1°
HISTORICAL EVOLUTION OF THE DISEASE

The origin of AIDS is unclear. The disease probably surfaced in
Africa in the 1960's, although isolated cases may have existed earlier.'" In retrospect, we (the authors) probably saw our first case of
AIDS in 1977 when we treated an intravenous drug user for a disseminated atypical mycobacterium infection (an opportunistic infection now commonly associated with AIDS). A few years later, in
1981, a clustering of Kaposi's sarcoma cases in young homosexuals

was first noted in the United States,12 while at the same time a disease process with persistent, generalized lymphadenopathy (swollen
glands) was also documented in homosexuals. 3 In addition, it was
7. Id.
8. Id. at 373-74.
9. Blattner, Biggar, Weiss, Melbye & Goedert, Epidemiology of Human T-Lymphotropic Virus Type III and the Risk of the Acquired Immunodeficiency Syndrome, 103 ANNALS INTERNAL MED. 665, 668 (1985).
10. For a technical definition of ARC, see Redfield, Markham, Salahuddin, Wright,
Sarngadharan & Gallo, Heterosexually Acquired HTLV-III/LAV Disease (AIDS-Related
Complex and AIDS), 254 J. A.M.A. 2094 (1985). ARC is also discussed in Jason, McDougal,
Dixon, Lawrence, Kennedy, Hilgartner, Aledort & Evatt, HTLV-Ill/LA V Antibody and Immune Status of Household Contacts and Sexual Partnersof Persons With Hemophilia, 255
J. A.M.A. 212 (1986).
11. See Williams, Stretton & Leonard, AIDS in 1959?, LANCET, Nov. 12, 1983, at 1136
(discussing the possibility that a patient diagnosed with cytomegalic inclusion disease and
Pneumocystls carinii infection may in fact have died from AIDS). See also Selik, Haverkos &
Curran, supra note 1, at 494 (noting two early cases: a Haitian man in Brooklyn, N.Y., in
whom Pneumocystis carinii pneumonia was diagnosed in 1959; a woman in Louisiana in
whom Pneumocystis carinii pneumonia was diagnosed in 1975).
12. A Cluster of Kaposi's sarcoma and Pneumocystis cariniiPneumonia among Homosexual Male Residents of Los Angeles and Orange Counties, California, 31 MORBIDITY &
MORTALITY WEEKLY REP. 305 (June 18, 1982).
13, Persistent,Generalized Lymphadenopathy among Homosexual Males, 31 MORBIDITY & MORTALITY WEEKLY REP. 249 (May 21, 1982). Reports of this disease were made by
physicians in major metropolitan areas in the United States. Of 57 patient records reviewed by
the CDC, the mean age of the patients was 33 years. All were male, 81% were white, 15%
were black, and 4% were Hispanic; 83% were single, 6% were married, and 11% divorced; 86%

http://scholarlycommons.law.hofstra.edu/hlr/vol14/iss1/2

2

Sicklick and Rubinstein: A Medical Review of AIDS

1985]

A MEDICAL REVIEW OF AIDS

not until 1983 that the existence of AIDS in children was generally

accepted, 14 although we saw our first pediatric case three years
earlier.
EPIDEMIOLOGY

The AIDS-causing virus has been isolated from blood, semen,
vaginal fluids, breast milk, saliva, and tears.15 However, the presence
of the virus cannot be equated with its risk of transmission. Although the AIDS virus may exist in saliva or tears, transmission via
these sources has not been documented. 6
The homosexual and bisexual populations constitute the largest
risk group to develop AIDS or ARC. 17 Recently, however, incidences
of the disease have become more noticeable among intravenous drug
users.18 Only a small number of patients fall into other known risk
groups, such as recipients of blood products"9 and sexual partners of
high risk group members.20 A small but constant percentage of patients have no apparent risk factor. 21 The pediatric patients usually
acquire the disease from their HTLV-III infected mothers,22 or, less
were homosexual and 14% were bisexual. Id.
14. Update: Acquired Immunodeficiency Syndrome-United States, 35
MORTALITY WEEKLY REP.

MORBIDITY

&

17, 19 (Jan. 17, 1986) [hereinafter cited as Update: United

States]. See also, Rubinstein, Sicklick, Gupta, Bernstein, Klein, Rubinstein, Spigland,
Fruchter, Litman, Lee & Hollander, Acquired Immunodeficiency with Reversed T4/T8 Ratios
in Infants Born to Promiscuous and Drug-Addicted Mothers, 249 J. A.M.A. 2350 (1983);
Gupta, Sicklick, Bernstein, Rubinstein & Rubinstein, Recurrent Infections, InterstitialPneumonia, Hypergammaglobulinemia, and Reversed T4/T8 Ratio in Children With High Antibody Levels to Epstein Barr Virus, Proceedings of the American Academy of Pediatrics
(1982).
15. Summary: Recommendationsfor Preventing Transmission of Infection with Human
T-Lymphotropic Virus Type Ill/Lymphadenopathy-Associated Virus in the Workplace, 34
MORBIDITY & MORTALITY WEEKLY REP. 681, 682 (Nov. 15, 1985) [hereinafter cited as
Preventing Transmission of Virus Type III]; Selwyn, AIDS: What is Now Known, Hosp.
PRAC., May 15, 1986, at 67, 73.
16. Selwyn, supra note 15, at 73; Recommendations for Preventing Possible Transmission of Human T-Lymphotropic Virus Type IlI/Lymphadenopathy-Associated Virus from
Tears, 34 MORBIDITY & MORTALITY WEEKLY REP. 533, 534 (Aug. 30, 1985).
17. Update: United States, supra note 14, at 19.
18. Id. Homosexual and bisexual males and intravenous drug abusers account for 90%
of the reported adult cases. Selwyn, supra note 15, at 69.
19. Update: United States, supra note 14, at 19. Transfusion-recipient cases account for
1%to 2% of all reported cases. Selwyn, supra note 15, at 69.
20. Update: United States, supra note 14, at 19.
21. Id. There is no identified risk in 3% to 4% of all reported cases. Selwyn, supra note
15, at 69.
22. See Preventing Transmission of Virus Type I1, supra note 15, at 682.
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frequently, through a blood transfusion. 3 In one case, transmission
through breast milk was postulated.24
There is compelling evidence that the disease is not transmitted
through casual contact. 25 The CDC, therefore, does not recommend
routine screening for HTLV-III infection in high risk groups, and
individuals infected with AIDS should not be restricted from work
unless they have another infection or illness which would warrant
such restriction.28
CLINICAL PRESENTATION

The majority of adults seen with AIDS present with either opportunistic infections,27 chronic diarrhea, recurrent pneumonias, or
unexplained weight loss. Others exhibit generalized lymphadenopathy, encephalitis, or recurrent, frequent, nonopportunistic infections, such as common bacterial infections. As the disease progresses,
the patient becomes more debilitated, experiences significant weight
loss and loss of appetite, and usually acquires additional infections.
Since some of these infections do not respond to known therapy, ultimately they may be the cause of death of the AIDS patient.
The pediatric AIDS patients present in a similar but somewhat
different way. While adult patients display massive weight loss, pediatric patients present as failures to thrive; these children are abnormally small in both height and weight for their age. Children also
exhibit recurrent infections, interstitial pneumonia, and chronic
Possible Transfusion-Associated Acquired Immune Deficiency Syndrome (AIDS)
31 MORBIDITY & MORTALITY WEEKLY REP. 652 (Dec. 10, 1982).
24. Ziegler, Cooper, Johnson & Gold, Postnatal Transmission of AIDS-Associated Retrovirus from Mother to Infant, LANCET, April 20, 1985, at 896. The child of a previously
healthy woman was delivered by caesarean section. Because of significant blood loss during the
23.

-California,

operation, the woman received a blood transfusion. She breast fed the infant for six weeks.
Thirteen months later the blood donor developed AIDS. The antibody to the AIDS virus was
identified in the infant. Since the mother was transfused after delivery, the baby was presumed
to have been infected via the mother's breast milk or some other form of close contact with his
mother. Id.
25. Preventing Transmission of Virus Type III, supra note 15, at 682. "There is currently no evidence of spread of LAV/HTLV-III by casual social contact even within households." World Health Organization Workshop: Conclusions and Recommendations on Acquired Immunodeficiency Syndrome, 253 J. A.M.A. 3385, 3385 (1985).
26. Preventing Transmission of Virus Type III, supra note 15, at 681.

27. Opportunistic infections are those "which occur due to the opportunity afforded by
the altered physiological state of the host. Thus when certain antibiotics or adrenal cortical

steroids are given for long periods, certain microorganisms which would otherwise be
nonpathogenic become pathogenic." C. TABER, TABER'S CYCLOPEDIC MEDICAL DICTIONARY 0-

19 (13th ed. 1977).
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diarrhea.
In addition to the infections and malignancies that accompany
the disease, significant neurological impairment often occurs. Adults
can develop either peripheral neuropathies (damage to the noncentral nervous system) or dementia (another sign of central nervous
system involvement). Children are often developmentally delayed
and on a CAT scan may show cortical atrophy (shrinking of the
gray matter of the brain).
DIAGNOSTIC TESTS

Until 1984, the diagnosis of AIDS was made by nonspecific
clinical and immunological tests.28 Currently, the most frequently
utilized tests are those used to determine whether a person has antibodies to HTLV-III. 29 These tests only document exposure to the
virus, not the presence of disease caused by the AIDS virus.30 Although these tests have no prognostic value, they remain useful as a
screening test for blood products.
The AIDS antibody tests may yield false positive or false negative results. Tests will be negative early in the course of the disease,
before the infected person can mount an antibody response. Thus, a
person may be infected with the disease in its early stages and nevertheless test negatively. If there is suspicion that the test result does
not fit the clinical course of the patient, the Western blot test,
should be performed. This is a more exact and more expensive test
that can be used as a backup in patient evaluation. It fingerprints the
virus and shows certain typical findings found in the HTLV-III virus. Detailed evaluation of the immune system, together with a thorough physical examination, is necessary before a definitive diagnosis
28.

The nonspecific clinical and immunological tests included assays for the ratio of

helper to suppressor cells. Initially, there was widespread publicity about the reversal of this
ratio when a greater number of suppressor cells were present because this reversal was thought
to be responsible for the immune system shutting off. It has subsequently been learned that

this ratio reversal occurs in many clinical findings, ranging from AIDS to conditions as simple
as minor respiratory infections. Thus, it is no longer considered a viable diagnostic test for

AIDS and only serves in screening the immune system. It was not until 1984 that R. C. Gallo,
at the National Cancer Institute, made discoveries which allowed definition of the HTLV-III

virus. Selwyn, supra note 15, at 73. Other studies followed, which confirmed the link between
HTLV-III and AIDS. Id.

29.

HTLV-III antibodies are "a reliable marker for the presence of live, infective virus,"

unlike virus antibodies which generally serve a protective function. Id.
30. Id.

31.

For a description of Western blot analysis, see Jason, McDougal, Dixon, Lawrence,

Kennedy, Hilgartner, Aledort & Evatt, supra note 10, at 213.
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can be established.32 However, it is important to realize that at the
present time, no definitive test to determine the presence of AIDS
exists.
THERAPY

No cure for AIDS has been found.3 3 Therapeutic attempts have
included the boosting of the body's own immune system and the use
of antiviral agents.3 4 To date, however, the best weapon to stem the
spread of the disease is avoidance of high risk situations. The longterm prognosis of presently healthy individuals in whom other infection with HTLV-III has been documented remains unclear. It is uncertain how many will progress to ARC or to full-blown AIDS. Several million people today are HTLV-III antibody positive, and, as
such, remain a potential reservoir for this infectious agent. Currently, AIDS is primarily restricted to high-risk groups; only the future will tell how this disease will affect individuals outside those
groups. The AIDS virus can change and thus affect its clinical
course for the better or for the worse.

32. Another method for evaluating the immune system is growing the lymphocytes
(white blood cells) of a patient in a test tube with nonspecific stimulants that ordinarily cause
the cells to proliferate. If these cells fail to proliferate properly when a radioactive tag is
added, it is compatable with the findings caused by the presence of the AIDS virus.
33. Selwyn, supra note 15, at 67, 82.
34. See Lawrence, The Immune System in AIDS, Sci. AM., Dec. 1985, at 84, 93.
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